116 related articles for article (PubMed ID: 7511132)
41. Brain and spinal cord kappa opiate receptors and pharmacological responses to U-50,488H in rats of differing ages.
Bhargava HN; Matwyshyn GA; Reddy PL; Veeranna
Pharmacol Biochem Behav; 1994 May; 48(1):87-91. PubMed ID: 8029307
[TBL] [Abstract][Full Text] [Related]
42. Neurophysiological evidence for increased kappa opioidergic control of spinal cord neurons in rats with unilateral inflammation at the ankle.
Stiller RU; Grubb BD; Schaible HG
Eur J Neurosci; 1993 Nov; 5(11):1520-7. PubMed ID: 8287195
[TBL] [Abstract][Full Text] [Related]
43. The selective kappa-opioid agonist, U-50,488H, produces antinociception in the rat via a supraspinal action.
Czlonkowski A; Millan MJ; Herz A
Eur J Pharmacol; 1987 Oct; 142(1):183-4. PubMed ID: 2826175
[No Abstract] [Full Text] [Related]
44. The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats.
Dosaka-Akita K; Tortella FC; Holaday JW; Long JB
J Pharmacol Exp Ther; 1993 Feb; 264(2):631-7. PubMed ID: 8382278
[TBL] [Abstract][Full Text] [Related]
45. Analgesia produced by intrathecal administration of the kappa opioid agonist, U-50,488H, on formalin-evoked cutaneous pain in the rat.
Pelissier T; Paeile C; Soto-Moyano R; Saavedra H; Hernández A
Eur J Pharmacol; 1990 Nov; 190(3):287-93. PubMed ID: 2272367
[TBL] [Abstract][Full Text] [Related]
46. Analgesic action of loperamide, an opioid agonist, and its blocking action on voltage-dependent Ca2+ channels.
Hagiwara K; Nakagawasai O; Murata A; Yamadera F; Miyoshi I; Tan-No K; Tadano T; Yanagisawa T; Iijima T; Murakami M
Neurosci Res; 2003 Aug; 46(4):493-7. PubMed ID: 12871771
[TBL] [Abstract][Full Text] [Related]
47. Turtle Flexion Reflex Motor Patterns Show Windup, Mediated Partly by L-type Calcium Channels.
Johnson KP; Tran SM; Siegrist EA; Paidimarri KB; Elson MS; Berkowitz A
Front Neural Circuits; 2017; 11():83. PubMed ID: 29163064
[TBL] [Abstract][Full Text] [Related]
48. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
Wilson JL; Nayanar V; Walker JS
Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
[TBL] [Abstract][Full Text] [Related]
49. Morphine or U-50,488 suppresses Fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious visceral stimulus in the rat.
Hammond DL; Presley R; Gogas KR; Basbaum AI
J Comp Neurol; 1992 Jan; 315(2):244-53. PubMed ID: 1545011
[TBL] [Abstract][Full Text] [Related]
50. Pre- and postsynaptic contributions of voltage-dependent Ca2+ channels to nociceptive transmission in rat spinal lamina I neurons.
Heinke B; Balzer E; Sandkühler J
Eur J Neurosci; 2004 Jan; 19(1):103-11. PubMed ID: 14750968
[TBL] [Abstract][Full Text] [Related]
51. Release by U-50,488H of [3H]serotonin from brain slices and spinal cord synaptosomes of U-50,488H-tolerant and nontolerant mice.
Ho BY; Takemori AE
J Pharmacol Exp Ther; 1990 Jul; 254(1):8-12. PubMed ID: 2164102
[TBL] [Abstract][Full Text] [Related]
52. L-type Ca2+ channel modulation by dihydropyridines potentiates kappa-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats.
Gullapalli S; Ramarao P
Neuropharmacology; 2002 Mar; 42(4):467-75. PubMed ID: 11955518
[TBL] [Abstract][Full Text] [Related]
53. Biochemical and functional interactions of a selective kappa opioid agonist with calcium.
VonVoigtlander PF; Ochoa MC; Lewis RA
Adv Exp Med Biol; 1987; 221():345-55. PubMed ID: 2829584
[TBL] [Abstract][Full Text] [Related]
54. Delta- and kappa-opioid agonists inhibit plasma extravasation induced by bradykinin in the knee joint of the rat.
Green PG; Levine JD
Neuroscience; 1992 Jul; 49(1):129-33. PubMed ID: 1328929
[TBL] [Abstract][Full Text] [Related]
55. Involvement of both L- and N-type voltage-dependent Ca2+ channels in KCl- and veratridine-evoked transmitter release from non-adrenergic, non-cholinergic nerves in the rabbit iris sphincter muscle.
Kageyama M; Fujita H; Nakata K; Shirasawa E
Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):638-44. PubMed ID: 9151304
[TBL] [Abstract][Full Text] [Related]
56. Blockade of U50,488H analgesia by antisense oligodeoxynucleotides to a kappa-opioid receptor.
Chien CC; Brown G; Pan YX; Pasternak GW
Eur J Pharmacol; 1994 Mar; 253(3):R7-8. PubMed ID: 8200413
[TBL] [Abstract][Full Text] [Related]
57. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs.
Brent PJ
Neuropharmacology; 1993 Aug; 32(8):751-60. PubMed ID: 8413839
[TBL] [Abstract][Full Text] [Related]
58. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
[TBL] [Abstract][Full Text] [Related]
59. Pharmacological dissection of Ca2+ channels in the rat aorta by Ca2+ entry modulators.
Rico I; Alonso MJ; Salaices M; Marín J
Pharmacology; 1990; 40(6):330-42. PubMed ID: 1700444
[TBL] [Abstract][Full Text] [Related]
60. Kappa-/mu-receptor interactions in the opioid control of the in vivo release of substance P-like material from the rat spinal cord.
Collin E; Mauborgne A; Bourgoin S; Mantelet S; Ferhat L; Hamon M; Cesselin F
Neuroscience; 1992 Nov; 51(2):347-55. PubMed ID: 1281527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
